Rocket Pharmaceuticals Inc RCKT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/10/24 EDT
22.72UNCH (UNCH)
Volume
31,949
Close
22.72quote price arrow down-0.61 (-2.61%)
Volume
369,982
52 week range
14.89 - 32.53
Loading...
  • Open23.49
  • Day High23.64
  • Day Low22.72
  • Prev Close23.33
  • 52 Week High32.53
  • 52 Week High Date12/28/23
  • 52 Week Low14.89
  • 52 Week Low Date08/21/23

Key Stats

  • Market Cap2.062B
  • Shares Out90.75M
  • 10 Day Average Volume0.67M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change-24.19

KEY STATS

  • Open23.49
  • Day High23.64
  • Day Low22.72
  • Prev Close23.33
  • 52 Week High32.53
  • 52 Week High Date12/28/23
  • 52 Week Low14.89
  • 52 Week Low Date08/21/23
  • Market Cap2.062B
  • Shares Out90.75M
  • 10 Day Average Volume0.67M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change-24.19

RATIOS/PROFITABILITY

  • EPS (TTM)-2.87
  • P/E (TTM)-7.92
  • Fwd P/E (NTM)-8.36
  • EBITDA (TTM)-253.957M
  • ROE (TTM)-55.38%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)4.80%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rocket Pharmaceuticals Inc

 

Profile

MORE
Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company. The Company is advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. Its lentiviral (LV) vector-based gene therapies target hematologic diseases and consist of late-stage programs for Fanconi Anemia, a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte...
Roderick Wong M.D.
Chairman of the Board
Gaurav Shah M.D.
Chief Executive Officer, Director
Kinnari Patel Pharm.D.
President, Chief Operating Officer, Head of Research and Development
Aaron Ondrey
Chief Financial Officer, Principal Financial Officer
John Militello CPA
Principal Accounting Officer, Vice President - Finance, Senior Controller, Treasurer
Mayo Pujols
Executive Vice President, Chief Technical Officer
Martin Wilson J.D.
General Counsel, Chief Corporate Officer
Address
350 5th Ave Ste 7530
New York, NY
10118-7501
United States

Top Peers

SYMBOLLASTCHG%CHG
KROS
Keros Therapeutics Inc
54.27-3.33-5.78%
DYN
Dyne Therapeutics Inc
26.00+0.05+0.19%
SANA
Sana Biotechnology Inc
7.56+0.06+0.80%
VERA
Vera Therapeutics Inc
41.32-1.01-2.39%
GERN
Geron Corp
3.80-0.08-2.06%